[PLX] YoY Quarter Result on 30-Sep-2019 [#Q3]

Stock
[PLX] Protalix BioTherapeutics, Inc.
Announcement Date
07-Nov-2019
Financial Year
2019
Quarter
30-Sep-2019 [#Q3]
Profit Trend
QoQ- 54.02%
YoY- 77.10%
Quarter Report
PLX's Result
PLX's Financial Summary
View:
Show?
Quarter Result
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
Revenue 14,183 12,054 10,790 14,248 663 7,526 4,670 20.32%
PBT -3,567 -4,199 -4,437 -3,560 -15,544 -11,437 -7,290 -11.22%
Tax 442 96 118 34 230 8 268 8.69%
NP -4,009 -4,199 -4,437 -3,560 -15,544 -11,437 -7,290 -9.48%
Tax Rate - - - - - - - -
Total Cost 18,192 16,253 15,227 17,808 16,207 18,963 11,960 7.23%
Ratio Analysis
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
NP Margin -28.27 -34.83 -41.12 -24.99 -2,344.49 -151.97 -156.10 -24.77%
Per Share
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
EPS -0.08 -0.09 -0.14 -0.24 -1.05 -0.86 -0.07 2.24%
EPS Diluted -0.08 -0.09 -0.14 -0.24 -1.05 -0.86 -0.07 2.24%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.